CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo
Xiaoli Wang(Shenyang Pharmaceutical University), Dongsheng Li(Ji Hua Laboratory), Yan Ding(Hubei University of Medicine), Xingrong Guo(Hubei University of Medicine), Yahong Yuan(Hubei University of Medicine), Wenmei Zhang(Beijing Anzhen Hospital)
Cited by 35
Related Papers
MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
|Human Cell|2017|136
20-HETE and Blood Pressure Regulation
|Cardiology in Review|2013|133
Neuroprotective effects of puerarin against beta-amyloid-induced neurotoxicity in PC12 cells via a PI3K-dependent signaling pathway
|Brain Research Bulletin|2011|93
Resveratrol increase myocardial Nrf2 expression in type 2 diabetic rats and alleviate myocardial ischemia/reperfusion injury (MIRI)
|Annals of Palliative Medicine|2019|83
Allelic loss of chromosome 13q14.3 in human oral cancer: Correlation with lymph node metastasis
|International Journal of Cancer|1998|71